Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Nurofen Plus recall expanded

August 31, 2011 Sales and Marketing MHRA, Nurofen, recalls

Last week’s recall of Reckitt Benckiser’s painkiller product Nurofen Plus has been expanded after two additional cases emerged where powerful …
News

FDA approves Pfizer’s lung cancer drug Xalkori

August 30, 2011 Sales and Marketing FDA, Pfizer, Xalkori, crizotinib

Pfizer’s lung cancer drug Xalkori has been approved by the FDA, a month ahead of schedule. Xalkori (crizotinib) is now …
News

New electronic submission validation criteria

August 29, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

On Thursday 1st September a new version of the validation criteria for electronic submissions for human medicines will come into …
News
Press release

MSD sways NICE with Simponi patient access scheme

August 26, 2011 Sales and Marketing NICE, Simponi, ankylosing spondylitis

A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …
News
Boehringer - Lilly's Trajenta (linagliptin)

Boehringer-Lilly’s Trajenta wins European approval

August 26, 2011 Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …
News

Reckitt painkiller packs may contain antipsychotics, says MHRA

August 26, 2011 Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports

Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …
News

Google fined $500m for online drug advertising

August 26, 2011 Medical Communications, Sales and Marketing Google Adwords, counterfeits, google

Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …
News

AkzoNobel appoints new investor relations director

August 25, 2011 Sales and Marketing appointment, sales and marketing

Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …
Appointment

Market access and the new NHS in England

August 25, 2011 Sales and Marketing NHS, NHS reforms

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Feature
Diabetes injection

Sharp increase in NHS diabetes prescribing costs

August 25, 2011 Sales and Marketing GP prescribing, NHS, diabetes, prescribing

NHS prescribing for diabetes has risen sharply, largely driven by the disease’s growing prevalence in the UK. Spending rose 41% …
News

NICE says no to BMS for second-line Orencia

August 25, 2011 Sales and Marketing BMS, NICE, Orencia, rheumatoid arthritis

In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have …
News

FDA approves Botox to treat urinary incontinence

August 25, 2011 Sales and Marketing Allergan, Botox, urinary incontinence

Botox has been approved in the US to treat urinary incontinence as manufacturer Allergan continues to expand the brand’s non-cosmetic …
News

AZ details US doctor payments

August 24, 2011 Sales and Marketing AstraZeneca, industry reputation, payments

AstraZeneca is shining a light on its activities in the US, disclosing for the first time how much it pays …
News

Spain to cut 2.4 billion euros from drugs bill with new generics rules

August 24, 2011 Sales and Marketing Spain, generic prescribing, generics

The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …
News

Blood cancer drug Adcetris approved by FDA

August 24, 2011 Sales and Marketing Adcetris, Cancer, Seattle Genetics, lymphoma

The FDA has approved Seattle Genetics’ blood cancer drug Adcetris for two forms of lymphoma. Adcetris (brentuximab vedotin) can now …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026